Navigation Links
Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF
Date:7/18/2008

SANTA MONICA, Calif., July 18 /PRNewswire-USNewswire/ -- Two consumer groups today filed an appeal in their challenge of a controversial patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF).

Consumer Watchdog, formerly The Foundation for Taxpayer and Consumer Rights, and the Public Patent Foundation appealed to the U.S. Patent Office's Board of Appeals and Interferences. The PTO examiner narrowed WARF's patent after the two groups requested a re-examination of the patent in July 2006. Initially all the patent claims were rejected, but this spring the PTO granted the narrowed claims.

The two groups noted that the patent challenge has already improved the situation for stem cell researchers; shortly after the PTO launched the re-examination, WARF announced a substantial easing of its licensing requirements.

"WARF executives were acting like arrogant bullies blinded by dollar signs," said John M. Simpson, Consumer Watchdog's Stem Cell Project Director. "Our challenge has engendered a more co-operative stance towards the stem cell research community on their part."

"When we filed this challenge, we fully expected to take an appeal if necessary," said Dan Ravicher, PUBPAT's Executive Director and the attorney representing Consumer Watchdog before the PTO in these challenges. "Although we won a substantial victory at the examiner level when WARF was forced to narrow their patent claims, we still believe that even the narrower patent is invalid and that's the issue we plan to contest with the PTO's Board of Appeals."

Joining the two consumer groups in the challenge from the beginning was Dr. Jeanne Loring, now director of the Center for Regenerative Medicine at the Scripps Institute. Later in the case Dr. Alan Trounson, then of Australia's Monash University and now president of the California Institute for Regenerative Medicine, Dr. Douglas Melton of Harvard and Dr. Chad Cowan of Harvard filed affidavits supporting the challenge.

"It's not just scientists that are affected by the patents," said Dr. Loring. "Patients and their families know that WARF's iron-fisted control of stem cells is slowing life-saving research."

The appeal will show that the creation of human embryonic stem cell lines was obvious in the light of work that had been done in other species. No other country in the world recognizes the WARF stem cell patent.

Get a copy of the appeal notice at this link: http://www.consumerwatchdog.org/resources/913PatentAppeal.pdf

Consumer Watchdog, formerly known as The Foundation for Taxpayer and Consumer Rights, is a leading non-profit and non-partisan consumer advocacy group. For more information visit us on the web at http://www.consumerwatchdog.org.

The Public Patent Foundation is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by undeserved patents and unsound patent policy. For more information, visit us on the web at http://www.pubpat.org/.


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumers Offer to Pay More to Satisfy Health Demands
2. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Naked Juice Brings Consumers Happiness by the Billions With First 100% Juice Smoothie Containing Probiotics
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What Theyll be Charged Under Nunez Plan
7. PA Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Perry County Dairy
8. Injuries, Deaths Tied to Consumer Drugs Rise Sharply
9. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
10. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
11. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: